NO996368D0 - Fremgangsmåte for fremstilling av enantiomerisk anriket N- derivatiserte lactamer - Google Patents

Fremgangsmåte for fremstilling av enantiomerisk anriket N- derivatiserte lactamer

Info

Publication number
NO996368D0
NO996368D0 NO996368A NO996368A NO996368D0 NO 996368 D0 NO996368 D0 NO 996368D0 NO 996368 A NO996368 A NO 996368A NO 996368 A NO996368 A NO 996368A NO 996368 D0 NO996368 D0 NO 996368D0
Authority
NO
Norway
Prior art keywords
lactams
derivatized
preparation
enantiomerically enriched
enantiomerically
Prior art date
Application number
NO996368A
Other languages
English (en)
Other versions
NO996368L (no
NO320081B1 (no
Inventor
Michael John Dawson
Mahmoud Mahmoudian
Christopher John Wallis
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO996368D0 publication Critical patent/NO996368D0/no
Publication of NO996368L publication Critical patent/NO996368L/no
Publication of NO320081B1 publication Critical patent/NO320081B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/02Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/006Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19996368A 1997-08-22 1999-12-21 Fremgangsmate for fremstilling av enantiomerisk rene N-derivatiserte laktamer og for enantiomerisk opplosning av en racemisk blanding derav. NO320081B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9717928.7A GB9717928D0 (en) 1997-08-22 1997-08-22 Process for the enatioselective hydrolysis of n-derivatised lactams
PCT/EP1998/005291 WO1999010519A1 (en) 1997-08-22 1998-08-20 Process for preparing enantiomerically enriched n-derivatised lactams

Publications (3)

Publication Number Publication Date
NO996368D0 true NO996368D0 (no) 1999-12-21
NO996368L NO996368L (no) 2000-02-21
NO320081B1 NO320081B1 (no) 2005-10-17

Family

ID=10817952

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19996368A NO320081B1 (no) 1997-08-22 1999-12-21 Fremgangsmate for fremstilling av enantiomerisk rene N-derivatiserte laktamer og for enantiomerisk opplosning av en racemisk blanding derav.

Country Status (35)

Country Link
US (1) US6340587B1 (no)
EP (1) EP1003903B1 (no)
JP (1) JP3565868B2 (no)
KR (1) KR100479894B1 (no)
CN (1) CN1133749C (no)
AP (1) AP1104A (no)
AR (1) AR016395A1 (no)
AT (1) ATE233323T1 (no)
AU (1) AU738897B2 (no)
BR (1) BR9810472B1 (no)
CA (1) CA2295017A1 (no)
CZ (1) CZ294302B6 (no)
DE (1) DE69811677T2 (no)
DK (1) DK1003903T3 (no)
EA (1) EA001964B1 (no)
EE (1) EE03934B1 (no)
ES (1) ES2193568T3 (no)
GB (1) GB9717928D0 (no)
HK (1) HK1025796A1 (no)
HR (1) HRP990408B1 (no)
HU (1) HU222657B1 (no)
ID (1) ID25830A (no)
IL (1) IL133541A (no)
IN (1) IN183908B (no)
IS (1) IS2201B (no)
NO (1) NO320081B1 (no)
NZ (1) NZ501880A (no)
PL (1) PL191108B1 (no)
PT (1) PT1003903E (no)
RS (1) RS49542B (no)
SI (1) SI1003903T1 (no)
SK (1) SK282782B6 (no)
TR (1) TR199903210T2 (no)
TW (1) TW589301B (no)
WO (1) WO1999010519A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59908429D1 (de) 1998-07-09 2004-03-04 Lonza Ag Verfahren zur herstellung von (1r,4s)-2-azabicyclo 2.2.1 hept-5-en-3-on-derivaten
DE19962543A1 (de) 1999-12-23 2001-07-05 Degussa Chromatographische Enantiomerentrennung von bicyclischen Lactamen
US6780635B2 (en) 2001-12-27 2004-08-24 Council Of Scientific And Industrial Research Process for the preparation of optically active azabicyclo heptanone derivatives
DE60211646T2 (de) * 2002-03-28 2007-05-24 Council Of Scientific And Industrial Research Verfahren zur Herstellung von optisch aktiven Azabicycloheptanone-Derivaten
HU227663B1 (en) * 2007-07-09 2011-10-28 Univ Szegedi Resolution process
KR101883750B1 (ko) 2010-01-27 2018-07-31 비이브 헬쓰케어 컴퍼니 항바이러스 치료
CN103695495B (zh) * 2014-01-14 2014-08-27 营口三征新科技化工有限公司 一种制备(1R,4s)-(-)-2-氮杂双环[2,2,1]庚-5-烯-3-酮的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0424064B1 (en) * 1989-10-16 1995-02-08 Chiroscience Limited Chiral azabicyloheptanone and a process for their preparation
GB9108384D0 (en) * 1991-04-19 1991-06-05 Enzymatix Ltd Bicycloheptanes
SK285228B6 (sk) * 1997-05-13 2006-09-07 Lonza Ag Spôsob výroby racemického alebo opticky aktívnehoderivátu 4-(hydroxymetyl)-2-cyklopenténu a racemicky N-butyryl-1-amino-4- (hydroxymetyl)-2-cyklopentén

Also Published As

Publication number Publication date
US6340587B1 (en) 2002-01-22
EE200000075A (et) 2000-10-16
BR9810472A (pt) 2000-09-19
CN1261405A (zh) 2000-07-26
PL337647A1 (en) 2000-08-28
KR100479894B1 (ko) 2005-03-30
EE03934B1 (et) 2002-12-16
JP3565868B2 (ja) 2004-09-15
TW589301B (en) 2004-06-01
EA001964B1 (ru) 2001-10-22
SI1003903T1 (en) 2003-08-31
IS2201B (is) 2007-02-15
IN183908B (no) 2000-05-13
AU9738698A (en) 1999-03-16
HRP990408A2 (en) 2000-04-30
NO996368L (no) 2000-02-21
JP2001504354A (ja) 2001-04-03
HUP0002661A3 (en) 2001-12-28
ID25830A (id) 2000-11-09
WO1999010519A1 (en) 1999-03-04
DE69811677T2 (de) 2003-10-16
KR20010014078A (ko) 2001-02-26
CZ294302B6 (cs) 2004-11-10
RS49542B (sr) 2007-02-05
EP1003903A1 (en) 2000-05-31
SK184499A3 (en) 2000-09-12
IL133541A (en) 2003-10-31
YU69399A (sh) 2002-06-19
CZ471699A3 (cs) 2000-06-14
DK1003903T3 (da) 2003-06-10
CN1133749C (zh) 2004-01-07
AP9901721A0 (en) 1999-12-31
AR016395A1 (es) 2001-07-04
IS5297A (is) 1999-12-14
PL191108B1 (pl) 2006-03-31
ES2193568T3 (es) 2003-11-01
HK1025796A1 (en) 2000-11-24
IL133541A0 (en) 2001-04-30
EP1003903B1 (en) 2003-02-26
NO320081B1 (no) 2005-10-17
HU222657B1 (hu) 2003-09-29
PT1003903E (pt) 2003-06-30
ATE233323T1 (de) 2003-03-15
EA199901059A1 (ru) 2000-08-28
HUP0002661A2 (hu) 2000-12-28
GB9717928D0 (en) 1997-10-29
TR199903210T2 (xx) 2000-07-21
BR9810472B1 (pt) 2011-01-11
HRP990408B1 (en) 2006-05-31
SK282782B6 (sk) 2002-12-03
AU738897B2 (en) 2001-09-27
CA2295017A1 (en) 1999-03-04
AP1104A (en) 2002-09-04
NZ501880A (en) 2001-08-31
DE69811677D1 (de) 2003-04-03

Similar Documents

Publication Publication Date Title
NO992875D0 (no) Fremstilling av enantiomert anriket threo-metylfenidat
NO306943B1 (no) Fremgangsmåte for fremstilling av enantiomerene av O- demetyltramadol
NO20000788D0 (no) Fremgangsmåte for fremstilling av aromatiske aminer
NO20000189L (no) Fremgangsmõte for fremstilling av heparin
NO996368D0 (no) Fremgangsmåte for fremstilling av enantiomerisk anriket N- derivatiserte lactamer
NO20003454D0 (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
NO993912D0 (no) Fremgangsmåte for fremstilling av eprosartan
NO993913D0 (no) Fremgangsmåte for fremstilling av eprosartan
EE03393B1 (et) Protsess enantiomeerselt puhta asetidiin-2-karboksüülhappe saamiseks
DK0906255T3 (da) Fremgangsmåde til fremstilling af enantiomert ren azetidin-2-carboxylsyre
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
HUP0204424A3 (en) Method for the preparation of enantiomerically enriched compounds
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
NO303495B1 (no) FremgangsmÕte til fremstilling av N-alkyl-laktamer
NO981499D0 (no) Fremgangsmåte for fremstilling av titandioksyd
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
DK0921111T3 (da) Fremgangsmåde til fremstilling af substituerede anthraquinoner
NO961577L (no) Fremgangsmåte for fremstilling av tre-polymer-kompositter
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler
NO995939D0 (no) Fremgangsmåte for fremstilling av chirale 3,4-dehydroproliner

Legal Events

Date Code Title Description
MK1K Patent expired